p70 Ribosomal S6 kinase is required for airway smooth muscle cell size enlargement but not increased contractile protein expression.

We examined the contribution of p70 ribosomal S6 kinase (p70S6K) to airway smooth muscle hypertrophy, a structural change found in asthma. In human airway smooth muscle cells, transforming growth factor (TGF)-beta, endothelin-1, and cardiotrophin-1 each induced phosphorylation of p70S6K and ribosomal protein S6 while increasing cell size, total protein synthesis, and relative protein abundance of alpha-smooth muscle actin and SM22. Transfection of myocytes with siRNA against either p70S6K or S6, or infection with retrovirus encoding a kinase-dead p70S6K, reduced cell size and protein synthesis but had no effect on contractile protein expression per mg total protein. Infection with a retrovirus encoding a constitutively active, rapamycin-resistant (RR) p70S6K increased cell size but not contractile protein expression. siRNA against S6 decreased cell size in myocytes expressing RR p70S6K. Finally, TGF-beta treatment, but not RR p70S6K expression, increased KCl-induced fractional shortening. Together, these data suggest that p70S6K activation is both required and sufficient for airway smooth muscle cell size enlargement but not contractile protein expression. Further, ribosomal protein S6 is required for p70S6K-mediated cell enlargement. Finally, we have shown for the first time in a functional cell system that p70S6K-mediated myocyte enlargement alone, without preferential contractile protein expression, is insufficient for increased cell shortening.

[1]  W. Henderson,et al.  Airway smooth muscle hyperplasia and hypertrophy correlate with glycogen synthase kinase-3(beta) phosphorylation in a mouse model of asthma. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[2]  D. Fingar,et al.  Inhibition of Glycogen Synthase Kinase-3β Is Sufficient for Airway Smooth Muscle Hypertrophy* , 2008, Journal of Biological Chemistry.

[3]  D. Fingar,et al.  Transforming growth factor-β induces airway smooth muscle hypertrophy , 2006 .

[4]  Steven P. Gygi,et al.  mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events , 2005, Cell.

[5]  D. Fingar,et al.  4E-binding protein phosphorylation and eukaryotic initiation factor-4E release are required for airway smooth muscle hypertrophy. , 2005, American journal of respiratory cell and molecular biology.

[6]  T. Bai,et al.  Cardiotrophin-1 alters airway smooth muscle structure and mechanical properties in airway explants. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[7]  J. Blenis,et al.  Deletion of Ribosomal S6 Kinases Does Not Attenuate Pathological, Physiological, or Insulin-Like Growth Factor 1 Receptor-Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy , 2004, Molecular and Cellular Biology.

[8]  P. Woodruff,et al.  Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. , 2004, American journal of respiratory and critical care medicine.

[9]  E. Raz,et al.  Immunostimulatory DNA inhibits transforming growth factor-beta expression and airway remodeling. , 2004, American journal of respiratory cell and molecular biology.

[10]  J. McConville,et al.  K Regulates Contractile Protein Accumulation in Airway Myocyte Differentiation , 2004 .

[11]  A. Halayko,et al.  Expression and effects of cardiotrophin‐1 (CT‐1) in human airway smooth muscle cells , 2003, British journal of pharmacology.

[12]  J. Kamei,et al.  Phosphatidylinositol 3-kinase in angiotensin II-induced hypertrophy of vascular smooth muscle cells. , 2003, European journal of pharmacology.

[13]  M. Aubier,et al.  Airway structural alterations selectively associated with severe asthma. , 2003, American journal of respiratory and critical care medicine.

[14]  M. Laviolette,et al.  Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[15]  P. O'Byrne,et al.  Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. , 2002, American journal of respiratory cell and molecular biology.

[16]  J. Blenis,et al.  Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. , 2002, Genes & development.

[17]  K. Sekizawa,et al.  Increases in collagen type I synthesis in asthma: the role of eosinophils and transforming growth factor‐bβ , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  C. Rommel,et al.  Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways , 2001, Nature Cell Biology.

[19]  C. Proud,et al.  Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase , 2001, The EMBO journal.

[20]  M. Mann,et al.  p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  W. J. Wu,et al.  Cdc42 Stimulates RNA Splicing via the S6 Kinase and a Novel S6 Kinase Target, the Nuclear Cap-binding Complex* , 2000, The Journal of Biological Chemistry.

[22]  E. Hafen,et al.  Drosophila S6 kinase: a regulator of cell size. , 1999, Science.

[23]  F. Saulnier,et al.  Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. , 1999, American journal of respiratory and critical care medicine.

[24]  M. Palacín,et al.  p70 S6 kinase activation is not required for insulin-like growth factor-induced differentiation of rat, mouse, or human skeletal muscle cells. , 1998, Endocrinology.

[25]  Stefano Fumagalli,et al.  Disruption of the p70s6k/p85s6k gene reveals a small mouse phenotype and a new functional S6 kinase , 1998, The EMBO journal.

[26]  R. Martin,et al.  Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. , 1997, American journal of respiratory cell and molecular biology.

[27]  M. Jordana,et al.  Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. , 1996, American journal of respiratory cell and molecular biology.

[28]  P. Howarth,et al.  Endothelin in bronchoalveolar lavage fluid and its relation to airflow obstruction in asthma. , 1995, American Journal of Respiratory and Critical Care Medicine.

[29]  P. Sassone-Corsi,et al.  Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: An alternative route to mitogen-induced gene expression , 1994, Cell.

[30]  M. Ebina,et al.  Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. , 1993, The American review of respiratory disease.

[31]  H. Counihan,et al.  Eridothelin immunoreactivity of airway epithelium in asthmatic patients , 1991, The Lancet.

[32]  A. Halayko,et al.  Endothelin-1 induces hypertrophy and inhibits apoptosis in human airway smooth muscle cells. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[33]  D. Fingar,et al.  Transforming growth factor-beta induces airway smooth muscle hypertrophy. , 2006, American journal of respiratory cell and molecular biology.